Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
82.27
+0.28 (0.34%)
At close: Nov 5, 2025, 4:00 PM EST
83.34
+1.07 (1.30%)
After-hours: Nov 5, 2025, 7:54 PM EST
Inhibrx Biosciences Stock Forecast
Stock Price Forecast
There have not been any analyst price target forecasts for Inhibrx Biosciences in the last 12 months.
Price Target: n/a
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Inhibrx Biosciences stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 22, 2025 |
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 15, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 18, 2025 |
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jan 22, 2025 |
| JMP Securities | JMP Securities | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Jul 23, 2024 |
Financial Forecast
Revenue This Year
1.33M
from 200.00K
Increased by 563.00%
Revenue Next Year
4.39M
from 1.33M
Increased by 230.77%
EPS This Year
-8.28
from 112.62
EPS Next Year
-9.51
from -8.28
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 1.4M | 4.5M |
| Avg | 1.3M | 4.4M |
| Low | 1.3M | 4.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 582.5% | 240.5% |
| Avg | 563.0% | 230.8% |
| Low | 537.0% | 217.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -8.53 | -9.79 | |
| Avg | -8.28 | -9.51 | |
| Low | -7.96 | -9.13 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.